← back to search

Peng Gao

Hebei Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, and Circular RNAs in diseases.
h-index
37
citations
4,816
works
197
NIH funding
primary concept
email

Recent publications

Development of a predictive model for septic shock-associated acute skin failure using readily available clinical variables
BMC Infectious Diseases 2025cited by 1position: middledoi
Comparison of traditional and suctioning ureteral access sheath during retrograde intrarenal surgery in the treatment of renal calculi
Langenbeck s Archives of Surgery 2024cited by 18position: middledoi
Chemoproteomics-based profiling reveals potential antimalarial mechanism of Celastrol by disrupting spermidine and protein synthesis
Cell Communication and Signaling 2024cited by 12position: firstdoi
CALCR exacerbates renal cell carcinoma progression via stabilizing CD44
Aging 2024cited by 6position: middledoi
What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis
Immunopharmacology and Immunotoxicology 2024cited by 1position: middledoi
LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
Molecular Cancer 2023cited by 75position: lastdoi
Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate
Acta Pharmacologica Sinica 2023cited by 38position: middledoi
Fibrocyte: A missing piece in the pathogenesis of fibrous epulis
Oral Diseases 2023cited by 3position: middledoi
CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis
Oncogene 2022cited by 86position: lastdoi
Profiling the peripheral blood T cell receptor repertoires of gastric cancer patients
Frontiers in Immunology 2022cited by 6position: middledoi
lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus
Cell Death and Differentiation 2021cited by 196position: lastdoi
LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer
British Journal of Cancer 2020cited by 98position: lastdoi
SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer
Oncogene 2020cited by 96position: lastdoi
The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer
Pathology - Research and Practice 2020cited by 9position: middledoi
Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer
Oncogene 2019cited by 62position: lastdoi
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer
Cancer Research 2018cited by 192position: lastdoi
SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
Journal of Experimental & Clinical Cancer Research 2018cited by 70position: lastdoi
KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer
Oncogene 2017cited by 87position: lastdoi
Diagnostic significance of urinary long non-coding PCA3 RNA in prostate cancer
Oncotarget 2017cited by 28position: middledoi
Suppression of <scp>SPIN1</scp>‐mediated <scp>PI3K</scp>–Akt pathway by <scp>miR</scp>‐489 increases chemosensitivity in breast cancer
The Journal of Pathology 2016cited by 121position: lastdoi
C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer
Cancer Letters 2015cited by 80position: lastdoi
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers
Oncotarget 2015cited by 79position: lastdoi
Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies
Mutagenesis 2013cited by 48position: firstdoi
RETRACTED ARTICLE: The molecular mechanism of microRNA-145 to suppress invasion–metastasis cascade in gastric cancer
Oncogene 2012cited by 151position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Haiting Liu · Shandong University7 papers (2015–2022)Ran‐Ran Ma · Shandong University6 papers (2015–2021)Hui Zhang · Heilongjiang University of Chinese Medicine5 papers (2015–2020)Duan‐Bo Shi · Shandong University4 papers (2015–2020)Ai‐Yan Xing · Qilu Hospital of Shandong University3 papers (2015–2016)Guo‐Hao Zhang · Shandong University3 papers (2020–2022)Ya‐Wen Wang · Southwest Jiaotong University3 papers (2015–2018)Xiangyu Guo · Shandong University3 papers (2015–2023)Wenjie Zhu · Southwest University of Science and Technology2 papers (2021–2022)Zhaohui Xing · Harbin Medical University2 papers (2024–2024)D-B Shi · Shandong University2 papers (2012–2017)Guiying Guo · Nanchang University2 papers (2024–2024)Xu Chen · University of Southern California2 papers (2015–2022)Jigang Wang · Qingdao University2 papers (2023–2024)Xiangyu Guo · Shandong University2 papers (2021–2022)Jie Zheng · Shandong University2 papers (2019–2023)Haiyang Yan · Harbin Medical University2 papers (2024–2024)Yuhong Li · Shandong University2 papers (2015–2020)R-R Ma · Shandong University1 papers (2017–2017)Dingding Zhao · Soochow University1 papers (2017–2017)